Uric acid levels and all-cause mortality in peritoneal dialysis patients

Kidney and Blood Pressure Research

Volumn 37, Issue 2-3, 2013, Pages 181-189

  Feng, Sheng ^a   Jiang, Linseng ^a   Shi, Yongbing ^a   Shen, Huaying ^a   Shi, Xiaosong ^a   Jin, Donghua ^a   Zeng, Ying ^a   Wang, Zhi ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Mortality; Peritoneal dialysis; Uric acid

Indexed keywords

SERUM ALBUMIN; URIC ACID;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URIC ACID BLOOD LEVEL; CAUSE OF DEATH; CONTROLLED STUDY; END STAGE RENAL DISEASE; LABORATORY TEST; RISK FACTOR; SURVIVAL;

AGED; CAUSE OF DEATH; COMORBIDITY; FEMALE; FORECASTING; HUMANS; HYPERURICEMIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; URIC ACID;

EID: 84878824545     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000350143     Document Type: Article

References (25)

1. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT: Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med 2004;164:1546-1551. (Pubitemid 38970476)
2. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y: Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006;47:195-202. (Pubitemid 43189763)
3. Chen JH, Chuang S Y, Chen HJ, Yeh W T, Pan WH: Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A chinese cohort study. Arthritis Rheum 2009;61:225-232.
4. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek J W, Collins AJ, Levey AS, Menon V: Uric acid and long-term outcomes in ckd. Am J Kidney Dis 2009;53:796-803.
5. Hsu S P, Pai M F, Peng YS, Chiang CK, Ho TI, Hung K Y: Serum uric acid levels show a 'j-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004;19:457-462.
6. Suliman ME, Johnson RJ, Garcia-Lopez E, Qureshi AR, Molinaei H, Carrero JJ, Heimburger O, Barany P, Axelsson J, Lindholm B, Stenvinkel P: J-shaped mortality relationship for uric acid in ckd. Am J Kidney Dis 2006;48:761-771. (Pubitemid 44740052)
7. Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P, Johnson RJ: Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 2009;29:79-85.
8. Latif W, Karaboyas A, Tong L, Winchester J F, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin N W, Sen A, Robinson BM, Saran R: Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol 2011;6:2470-2477.
9. Tang Z, Cheng LT, Li H Y, Wang T: Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 2009;29:368-373.
10. Park J T, Kim DK, Chang TI, Kim H W, Chang JH, Park S Y, Kim E, Kang S W, Han DS, Yoo TH: Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant 2009;24:3520-3525.
11. Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA: Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, evans county, georgia. Arch Intern Med 1973;132:401-410.
12. Etiology of end-stage renal disease reported SOCIETY OF NEPHROLOGY, CHINESE MEDICAL ASSOCIATION: The report about the registration of dialysis and transplantation in China. Chin J Nephrol 2001:17;77-78.
13. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P: Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The piuma study. Hypertension 2000;36:1072-1078.
14. Mazza A, Zamboni S, Rizzato E, Pessina AC, Tikhonoff V, Schiavon L, Casiglia E: Serum uric acid shows a j-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The cardiovascular study in the elderly (castel). Acta Diabetol 2007;44:99-105. (Pubitemid 47313091)
15. Ford ES: Uric acid and mortality from all-causes and cardiovascular disease among adults with and without diagnosed diabetes: Findings from the national health and nutrition examination survey III linked mortality study. Diabetes Res Clin Pract 2011;93:e84-86.
16. Wu YQ, Li J, Xu YX, Wang YL, Luo Y Y, Hu D Y, Liu WJ, Yang M, Pi L, Wang MS, Wang J Y, Zhao SM, Li MJ: Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban chinese patients. Chin Med J (Engl) 2010;123:1387-1391.
17. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417, 734 men and women in the apolipoprotein mortality risk study (amoris). J Intern Med 2009;266:558-570.
18. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-1742. (Pubitemid 40577708)
19. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH: Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010;28:1234-1242.
20. Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis D P, Elisaf MS: Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 2005;258:435-441. (Pubitemid 41546559)
21. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-631. (Pubitemid 43724964)
22. Yamamoto Y, Ogino K, Igawa G, Matsuura T, Kaetsu Y, Sugihara S, Matsubara K, Miake J, Hamada T, Yoshida A, Igawa O, Yamamoto T, Shigemasa C, Hisatome I: Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Hypertens Res 2006;29:915-921. (Pubitemid 46062122)
23. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-1190. (Pubitemid 36706063)
24. Termorshuizen F, Korevaar JC, Dekker F W, van Manen JG, Boeschoten E W, Krediet RT: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the netherlands cooperative study on the adequacy of dialysis (necosad)-2. Am J Kidney Dis 2003;41:1293-1302. (Pubitemid 36637986)
25. Haag-Weber M: The impact of residual renal function on survival. Nephrol Dial Transplant 2008;23:2123-2126. (Pubitemid 351957616)